SCHEMBL8686453

SCHEMBL8686453

O=C1NC(=O)/C(=C/c2cccc3c2ccn3Cc2ccc(F)c(F)c2)S1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 9/20 0.60
KMT2A Q03164 3/20 0.48
LMNA P02545 1/20 0.48
HPGD P15428 1/20 0.48
IGF1R P08069 1/20 0.48
TTR P02766 3/20 0.46
MEN1 O00255 2/20 0.46
AKR1B1 P15121 1/20 0.46
PIM1 P11309 1/20 0.41
PIM2 Q9P1W9 1/20 0.41
MGAM O43451 1/20 0.41
GAA P10253 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
NAT1 P18440 1/20 0.40
PTPN1 P18031 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811988 1.00 PARP1 (0.60) PARP1KMT2ALMNAHPGDIGF1R
SCHEMBL8813667 0.89 PARP1 (0.61) PARP1KMT2ALMNAIGF1RTTR
SCHEMBL8690587 0.89 PARP1 (0.61) PARP1KMT2ALMNAIGF1RTTR
SCHEMBL8687701 0.89 PARP1 (0.76) PARP1KMT2AHPGDIGF1RTTR
SCHEMBL8811679 0.89 PARP1 (0.76) PARP1KMT2AHPGDIGF1RTTR
SCHEMBL8811994 0.88 PARP1 (0.46) PARP1KMT2ALMNAHPGDMEN1
SCHEMBL8685837 0.88 PARP1 (0.62) PARP1KMT2AIGF1RTTRMEN1
SCHEMBL8811177 0.88 PARP1 (0.62) PARP1KMT2AIGF1RTTRMEN1
SCHEMBL8686629 0.88 PARP1 (0.64) PARP1KMT2ALMNAHPGDIGF1R
SCHEMBL8813928 0.88 PARP1 (0.64) PARP1KMT2ALMNAHPGDIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5811439-A ANTIDIABETIC AGENTS; SIDE EFFECT REDUCTION; ANTILEPEMIC AGENTS SENGA PHARMACEUTICAL LABORATORY INC. (JP) 1998-09-22 US disclosed
EP-0780389-A1 Thiazolidinedione derivatives, process for their preparation and pharmaceutical compositions containing them TOBISHI PHARMACEUTICAL CO., LTD. (JP) 1997-06-25 EP disclosed